Register | Login or

General Information

Websitecempra.com
CategoryBioTech
Employees
Founded1/06
DescriptionAntibiotics Developer

Offices

Corporate Headquarters
6340 Quadrangle Drive
Suite 100
Chapel Hill, NC, 27517
USA

Funding

Tags

Cempra

Cempra seeks to discover and develop well-differentiated medicines that cure bacterial infections and improve the quality of life for those with chronic illnesses. The company balances near-term product development opportunities, including the macrolide CEM-101, while investing in future products from new technologies to derive the next generation of antibiotics.

Milestones

  • Dollar
    Cempra received $10M in Series B funding. (7/1/07)
    Posted 6/17/09 at 10:46am via bioworld.com
  • Dollar
    Cempra received $22M in Series A funding. (4/1/06)
    Posted 6/17/09 at 10:46am via bioworld.com
  • Dollar
    Cempra received $46M in Series C funding. (6/2/09)
    Posted 6/17/09 at 10:44am via onbiovc.com

Videos

Screenshots

Sources

  1. Cempra Closes $46M Series C for Trials of Two Antibiotics (bioworld.com) [edit]
  2. Cempra Closes $46M Series C for Trials of Two Antibiotics (bioworld.com) [edit]
  3. Cempra Pharmaceuticals, Inc.: Series C $46M (onbiovc.com) [edit]
Edit This Page
Last Edited 6/17/09

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy